Package 51662-1457-1

{"route": ["INTRAVENOUS"], "spl_id": "132cd9f9-a36c-4e35-e063-6294a90aaa17", "openfda": {"unii": ["OLH94387TE"], "rxcui": ["1791240"], "spl_set_id": ["99c5813f-1ffe-0eaa-e053-2a95a90a751b"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (51662-1457-1)", "package_ndc": "51662-1457-1", "marketing_start_date": "20191215"}, {"sample": false, "description": "10 POUCH in 1 CASE (51662-1457-3)  / 1 VIAL, PATENT DELIVERY SYSTEM in 1 POUCH (51662-1457-2)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM", "package_ndc": "51662-1457-3", "marketing_start_date": "20221211"}], "brand_name": "DILTIAZEM HCI", "product_id": "51662-1457_132cd9f9-a36c-4e35-e063-6294a90aaa17", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "51662-1457", "generic_name": "DILTIAZEM HCI", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DILTIAZEM HCI", "active_ingredients": [{"name": "DILTIAZEM HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA075853", "marketing_category": "ANDA", "marketing_start_date": "20191215", "listing_expiration_date": "20261231"}